Yaz, Yasmin lawsuits could cause public panic, unwanted pregnancies
A Canadian doctor’s group worries that the large number of lawsuits filed against Yaz and Yasmin birth control pills because of deadly side effects may cause young women to panic and not use contraceptives, resulting in unwanted pregnancies.

Watson Pharmaceuticals has received approval from the Food and Drug Administration (FDA) under the Abbreviated New Drug Application for Zarah, its new oral contraceptive pill that serves as a generic version of Bayer’s best-selling birth control pill Yasmin. Yasmin and its generic equivalents sold approximately $97 million in the U.S. for the twelve months ending June 30, 2010.